Founders Financial Alliance, LLC Moderna, Inc. Transaction History

Founders Financial Alliance, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $182,861 - $339,882	-1,446 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $13,549 - $22,110	60 Added 4.33%	1,446 $367,000
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $15,533 - $33,912	70 Added 5.32%	1,386 $533,000
Q2 2021 Aug 02, 2021	BUY	$129.91 - $234.98 $170,961 - $309,233	1,316 New	1,316 $309,000
Q4 2020 Feb 04, 2021	SELL	$65.74 - $169.86 $72,642 - $187,695	-1,105 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $60,045 - $104,809	1,105 New	1,105 $78,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Founders Financial Alliance, LLC, based on Form 13F filings with the SEC.

Stay updated on Founders Financial Alliance, LLC with notifications on news.